Literature DB >> 21956405

Clusters of acute respiratory illness associated with human enterovirus 68--Asia, Europe, and United States, 2008-2010.

.   

Abstract

In the past 2 years, CDC has learned of several clusters of respiratory illness associated with human enterovirus 68 (HEV68), including severe disease. HEV68 is a unique enterovirus that shares epidemiologic and biologic features with human rhinoviruses (HRV). First isolated in California in 1962 from four children with bronchiolitis and pneumonia, HEV68 has been reported rarely since that time and the full spectrum of illness that it can cause is unknown. The six clusters of respiratory illness associated with HEV68 described in this report occurred in Asia, Europe, and the United States during 2008-2010. HEV68 infection was associated with respiratory illness ranging from relatively mild illness that did not require hospitalization to severe illness requiring intensive care and mechanical ventilation. Three cases, two in the Philippines and one in Japan, were fatal. In these six clusters, HEV68 disproportionately occurred among children. CDC learned of clusters of HEV68 from public health agencies requesting consultation or diagnostic assistance and from reports presented at scientific conferences. In each cluster, HEV68 was diagnosed by reverse transcription-polymerase chain reaction (RT-PCR) testing targeting the 5'-nontranslated region, followed by partial sequencing of the structural protein genes, VP4-VP2, VP1, or both, to give definitive, enterovirus type-specific information. This report highlights HEV68 as an increasingly recognized cause of respiratory illness. Clinicians should be aware of HEV68 as one of many causes of viral respiratory disease and should report clusters of unexplained respiratory illness to the appropriate public health agency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956405

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  96 in total

1.  Enterovirus D68 and disease severity: more questions than answers.

Authors:  Michelle Science; Upton Allen
Journal:  CMAJ       Date:  2015-10-13       Impact factor: 8.262

2.  Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice.

Authors:  Brett L Hurst; W Joseph Evans; Donald F Smee; Arnaud J Van Wettere; E Bart Tarbet
Journal:  Virology       Date:  2018-10-31       Impact factor: 3.616

Review 3.  Acute Flaccid Paralysis and Enteroviral Infections.

Authors:  Ari Bitnun; E Ann Yeh
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

4.  Detection of enterovirus D68 in Canadian laboratories.

Authors:  Todd F Hatchette; Steven J Drews; Elsie Grudeski; Tim Booth; Christine Martineau; Kerry Dust; Richard Garceau; Jonathan Gubbay; Tim Karnauchow; Mel Krajden; Paul N Levett; Tony Mazzulli; Ryan R McDonald; Alan McNabb; Samira Mubareka; Robert Needle; Astrid Petrich; Susan Richardson; Candy Rutherford; Marek Smieja; Raymond Tellier; Graham Tipples; Jason J LeBlanc
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

5.  Molecular epidemiology of enterovirus D68 from 2013 to 2014 in Philippines.

Authors:  Yuki Furuse; Natthawan Chaimongkol; Michiko Okamoto; Tadatsugu Imamura; Mariko Saito; Raita Tamaki; Mayuko Saito; Socorro P Lupisan; Hitoshi Oshitani
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

6.  Biennial Upsurge and Molecular Epidemiology of Enterovirus D68 Infection in New York, USA, 2014 to 2018.

Authors:  Victoria L Gilrane; Jian Zhuge; Weihua Huang; Sheila M Nolan; Abhay Dhand; Changhong Yin; Christian Salib; Faariah Shakil; Helen Engel; John T Fallon; Guiqing Wang
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

7.  Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness.

Authors:  Charu Rajput; Mingyuan Han; J Kelley Bentley; Jing Lei; Tomoko Ishikawa; Qian Wu; Joanna L Hinde; Amy P Callear; Terri L Stillwell; William T Jackson; Emily T Martin; Marc B Hershenson
Journal:  JCI Insight       Date:  2018-08-23

8.  Evaluation of a Real-Time Reverse Transcription-PCR Assay for Detection of Enterovirus D68 in Clinical Samples from an Outbreak in New York State in 2014.

Authors:  Jian Zhuge; Eric Vail; Jeffrey L Bush; Lauren Singelakis; Weihua Huang; Sheila M Nolan; Janet P Haas; Helen Engel; Millicent Della Posta; Esther C Yoon; John T Fallon; Guiqing Wang
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

9.  Clinical severity of pediatric respiratory illness with enterovirus D68 compared with rhinovirus or other enterovirus genotypes.

Authors:  Dominik Mertz; Abdulsalam Alawfi; Jeffrey M Pernica; Candy Rutherford; Kathy Luinstra; Marek Smieja
Journal:  CMAJ       Date:  2015-10-13       Impact factor: 8.262

Review 10.  Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality.

Authors:  Kevin Messacar; Edwin J Asturias; Alison M Hixon; Coretta Van Leer-Buter; Hubert G M Niesters; Kenneth L Tyler; Mark J Abzug; Samuel R Dominguez
Journal:  Lancet Infect Dis       Date:  2018-02-23       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.